Objective Experimental evidence suggests that changes in the fetal myocardium result from intrauterine effects of maternal diabetes mellitus and obesity. The aim of this study was to assess fetal cardiac function using two-dimensional speckle-tracking echocardiography to determine the effects of maternal diabetes and obesity on the fetal myocardium.
INTRODUCTION
In the USA, 12 million women aged > 20 years have diabetes mellitus (DM), 27 million women have prediabetes and more than one-third (34.9%) of adults are obese 1, 2 . Experimental evidence suggests that intrauterine effects of maternal DM and obesity cause changes in the fetal myocardium 3, 4 . Epidemiological data link these maternal diseases to early cardiovascular disease in the offspring 5 . This has increasing relevance in the context of the high prevalence of diabetes and obesity in women of childbearing age. For example, cardiac hypertrophy and contractile dysfunction occur in offspring of mice with maternal obesity and DM via lipotoxicity, glucose intolerance and mitochondrial dysfunction 3 . Maternal obesity induces myocardial fibrosis in the fetal sheep model by causing increased myocardial connective tissue accumulation 4 . Children of mothers with DM have been found to be at increased risk of being overweight and obese at 7 years of age 6 . A study of Pima Indians conducted by the National Institute of Health found higher systolic blood pressure and levels of glycated hemoglobin (HbA1c) in offspring of diabetic mothers 5 . Two-dimensional speckle-tracking echocardiography (2D-STE) is an angle-independent technique for assessing myocardial deformation 7 . Measurement of deformation parameters, strain and strain rate by 2D-STE has allowed detection of preclinical myocardial dysfunction in children and adults 7, 8 . This technique has recently been validated in fetal echocardiography and has been used to evaluate growth-restricted fetuses 9, 10 . Because of the known teratogenic effects of maternal DM, fetal echocardiography is part of routine screening for congenital heart defects and hypertrophic cardiomyopathy in pregnant women with DM [11] [12] [13] [14] . We hypothesized that fetal cardiac function is altered in maternal systemic diseases such as DM and obesity, and sought to determine prospectively the morphological manifestations of those disease states in the fetal heart. The specific aim of this study was to test this hypothesis by performing detailed fetal echocardiography including 2D-STE deformation analyses in fetuses of mothers with DM (FDM) and obesity (FO), and in normal control fetuses (FC).
SUBJECTS AND METHODS

Study population
This was a cross-sectional bi-institutional case-control study of 178 fetuses (82 FDM, 26 FO and 70 FC). Cases were enrolled from July 2013 to April 2015 and gestational age-matched controls were recruited from 2012 to 2015. All FDM were enrolled at Bronx Lebanon Hospital Center (Bronx, NY, USA). Of the 26 FO, 16 were enrolled at this center. The remaining FO and all FC were recruited at Children's Hospital and Medical Center (Omaha, NE, USA).
All fetuses in the FDM and FO groups were referred for standard clinical indications. Fetuses with arrhythmias, congenital heart disease, known genetic and chromosomal abnormalities, multiple gestation and a family history of known cardiomyopathy or early myocardial infarction and hypercholesterolemia were excluded. Singleton FDM and/or FO with structurally normal hearts without hypertrophy were included as cases if the mothers agreed to participate and gave informed consent. Cardiac hypertrophy was assessed based on gestational age and previously published nomograms 15 . FC pregnancies were recruited following advertisement in the hospital news bulletin inviting participation in a longitudinal study of normal fetuses. Gestational age-matched singleton fetuses of mothers without DM or obesity, with structurally and functionally normal hearts, and with the following additional inclusion criteria were included as FC: estimated fetal weight within the 10 th and 90 th percentiles; maternal age > 18 years; and no maternal history of medical, surgical or obstetric complications. Gestational age was based on the beginning of the last menstrual period and verified by sonographic measurement of the crown-rump length in early pregnancy.
Fetuses with an ultrasound image of poor quality that was inadequate for postprocessing by 2D-STE were excluded from analysis. The Institutional Review Boards at both institutions approved the study protocols. After initial screening, 115 fetuses were deemed eligible for inclusion as FDM cases, of which 27 mothers declined to participate and six were excluded due to poor transabdominal windows or inability to obtain images with sufficiently high frame rates (>80 frames/s) suitable for postprocessing by 2D-STE.
Maternal medical records were reviewed in all FDM cases to determine the type of DM, method of controlling DM and level of HbA1c within 3 months of the fetal echocardiography. Body mass index (BMI) was recorded in all mothers. BMI > 30 kg/m 2 was considered obese.
Imaging protocol
A common protocol for fetal echocardiography was detailed prior to initiation of the study at both centers. All fetal echocardiograms were performed using this protocol and according to published guidelines for fetal echocardiography 16 using a high-resolution ultrasound system (Vivid 7 or Vivid E9, GE Healthcare, Milwaukee, WI, USA) equipped with a 4-6-MHz abdominal transducer or a C2-9-D curved-array fetal transducer. Zoom-magnified, two-dimensional grayscale cineloop images at frame rates of ≥ 80 frames/s were obtained. Image-acquisition adjustments, such as narrow sector width, focus or frequency adjustment, and tissue harmonic function were used to optimize the frame rate. Power was kept at < 100 mW/cm 2 . Because there is no electrocardiographic gating on fetal echocardiography, 3-5-s image datasets were captured in the following views: apical or basal four-chamber view in transverse section of the fetus and left ventricular short-axis view at mid-papillary muscle level in sagittal section of the fetus. Raw datasets were stored in Digital Imaging and Communication in Medicine (DICOM) format.
Echocardiography
Fetal interventricular septal (IVS) thickness was measured in the apical or basal four-chamber view in end diastole, just below the level of the atrioventricular valves on the zoom-magnified images 15 . Simultaneous inflow and outflow pulsed-wave spectral Doppler was used to calculate left ventricular myocardial performance index (MPI) (isovolumic relaxation time (IVRT) + isovolumic contraction time/ejection time) 17, 18 . The pulsed-wave Doppler cursor (1-3-mm gate) was placed just inferior to the mitral valve in the left ventricular outflow tract in the apical/basal five-chamber view to obtain the Doppler tracing. Isovolumic contraction time was measured from the end of the mitral valve late filling phase (A-wave) to the beginning of the systolic waveform. IVRT was measured from the end of the aortic systolic waveform to the beginning of the mitral valve early filling wave (E-wave). Ejection time was measured in the same cardiac cycle as the duration of the aortic systolic waveform. Spectral pulsed-wave Doppler interrogation of the left ventricular inflow was performed to obtain mitral early-to-late diastolic filling ratio (E : A ratio). The interrogation beam was aligned parallel and as close as possible to the mitral valve inflow in all examinations. 
Deformation analysis
Analysis was performed on two-dimensional grayscale DICOM image datasets to derive left ventricular longitudinal, circumferential and radial deformation by offline postprocessing (Image-Arena Version 4.6 Build 4.6.2.12, Unterschleissheim, Tomtec, Germany). This software allows vendor neutral deformation analysis on DICOM datasets. The DICOM image data were deidentified prior to deformation analysis at both centers, and patient diagnosis was blinded at the time of the analysis. The technique involved manual tracing by A.K. and L.L. followed by semiautomated quantification by the software. Left ventricular end diastole was identified from the image frame just prior to complete mitral valve closure 19 . A single cardiac cycle was selected for analysis, starting from the end-diastolic frame. The endocardium was traced manually from the basal septum to the basal lateral wall, followed by automated quantification to obtain longitudinal strain and strain rate. Global longitudinal strain (GLS) was defined as the relative difference between the entire endocardial contour length (annulus to annulus) in end diastole (L1) and end systole (L0) 19 (GLS = (L1 -L0)/L0 × 100). An average strain graph was computed automatically based on six segmental strain graphs ( Figure 1 ). The negative peak of the average graph was defined as average peak strain and strain rate was the rate of change in strain. Similar tracing was performed in the left ventricular short axis to obtain circumferential and radial strain data. Visual assessment was made to ensure adequate tracking of all myocardial segments and, if necessary, manual contour correction was performed (Videoclip S1).
Statistical analysis
The Anderson-Darling test for normality was applied to all echocardiography variables. Descriptive data were expressed as mean ± SD for normally distributed data and median and interquartile range for non-normally distributed data. Non-parametric differences within variables of the four groups (control, maternal diabetes without obesity, maternal diabetes and maternal obesity) with non-normally distributed data were examined using Kruskal-Wallis test. Pairwise comparisons between individual groups were performed only if the Kruskal-Wallis test detected differences among groups. Non-parametric pairwise comparisons were adjusted for multiple comparisons using Dunn's test. For normally distributed variables, ANOVA was used to assess for differences among groups. Pairwise t-tests with Bonferroni adjustment for multiple comparisons were undertaken only if ANOVA detected differences among groups. P < 0.0167 was considered significant for multiple comparisons.
To assess intraobserver and interobserver agreement, all measurements were repeated (> 4 weeks after the first measurement) in 10 randomly chosen subjects from the entire cohort by the same and by a second blinded
HbA1c ≤ 6.4% (n = 44) HbA1c > 6.4% (n = 28) HbA1c unknown (n = 10) Fetuses (n = 178) Figure 2 Flowchart of study cohort of fetuses of mothers with diabetes mellitus (FDM) or obesity (FO) and gestational age-matched normal control fetuses (FC). *Body mass index unknown for one woman. DM, diabetes mellitus; HbA1c, glycated hemoglobin.
observer. Bland-Altman plots and intraclass correlation coefficients were derived to assess these agreements 20 . Statistical analysis was performed using commercially available software (SPSS, version 11.0 and Minitab, version 17.0, SPSS, IBM Corp., Armonk, NY, USA). In the FDM group, 18 (22.0%) mothers controlled their DM by diet alone, 14 (17.1%) were taking oral medication and 50 (61.0%) were taking insulin at the time of the fetal echocardiography. The FDM cohort consisted of 44 women with controlled DM (HbA1c ≤ 6.4%) and 28 women with poorly controlled DM (HbA1c > 6.4%) 21 . Data on HbA1c were not available for 10 FDM at the time of fetal echocardiography. There were 12 (14.6%) mothers in the FDM group and five (19.2%) in the FO group with comorbid hypertension.
RESULTS
Characteristics of patient population
Estimated fetal weight (mean ± SD) was similar between FDM (964.7 ± 693.8 g) and FC (985 ± 670.4 g) groups. Mean estimated fetal weight was not calculated in the FO group due to missing data from 10 subjects. Umbilical artery (UA) Doppler was within normal range for FDM (UA pulsatility index (PI), 1.3 ± 0.27; UA resistance index (RI), 0.71 ± 0.09), FO (UA-PI, 1.4 ± 0.29; UA-RI, 0.76 ± 0.08) and FC (UA-PI, 1.0 ± 0.4; UA-RI, 0.7 ± 0.1) groups.
Strain analysis
Results of the 2D-STE analyses are provided in Table 1 . GLS and average radial strain were significantly lower in both FDM and FO compared with FC. Global circumferential strain was lower in FDM compared with FC. Average longitudinal systolic strain rate was lower in FDM and average circumferential systolic strain rate was lower in both FDM and FO compared with FC. Left ventricular ejection fraction was significantly lower in FDM and FO compared with FC, although values for all groups were in the normal range. As 60 women in the FDM group were obese, a separate subgroup comparison was made between non-obese FDM (n = 21, BMI not available in one woman) and FC. After adjustment for multiple comparisons, significant differences between non-obese FDM and FC were noted for GLS (-22.1 ± 7.4, P = 0.011), average longitudinal systolic strain rate (-1.25 ± 0.7, P = 0.005), global circumferential strain (-21.0 ± 5.9, P = 0.002), average circumferential systolic strain rate (-1.2 ± 0.7, P = 0.002) and average radial strain (11.3 ± 12.2, P = 0.006). The study was underpowered to detect differences within the FDM cohort between fetuses with maternal HbA1c > 6.4 vs ≤ 6.4%. Data are given as intraclass correlation coefficients (95% CI). ACSR, average circumferential systolic strain rate; ALSR, average longitudinal systolic strain rate; ARS, average radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.
Standard echocardiographic parameters
Measurements of standard fetal echocardiographic parameters are detailed for each group in Table 2 . Fetal IVS thickness was significantly greater and IVRT was significantly less in FDM compared with FC. There were no significant differences in left ventricular MPI or mitral E : A ratios between the groups. There was no significant difference in any parameter between FO and FC groups.
Intraobserver and interobserver reproducibility
Intraclass correlation coefficients were moderate for both intraobserver and interobserver comparisons of all strain parameters (Table 3) . Bland-Altman plots showed acceptable agreement between repeat measurements obtained 4 weeks apart by the first observer ( Figure S1 ) and between separate measurements obtained by two observers ( Figure S2 ).
DISCUSSION
STE is an echocardiographic tool applied increasingly in clinical practice to detect preclinical myocardial dysfunction 7 . The present investigation used 2D-STE to assess myocardial mechanics in FDM and FO. Our key finding was that subclinical unfavorable changes in myocardial contractility occur in both FDM and FO, and are unrelated to maternal obesity in FDM. Our results also confirm the feasibility and reproducibility of 2D-STE in fetal echocardiography.
Current practice guidelines state that fetal echocardiography to rule out congenital heart defects is recommended only in cases of pregestational DM or DM diagnosed in the first trimester, whereas gestational DM with good glycemic control is not an indication for fetal cardiac evaluation. In cases of poor glycemic control (HbA1c > 6.4%), fetal echocardiography may be considered in the third trimester to assess for ventricular hypertrophy 14 . The role of more advanced functional imaging, such as myocardial strain imaging used in the present study, is currently under investigation and, based on our results, seems promising.
We found that 2D-STE measures of myocardial function in FDM and FO were generally more consistent than traditional Doppler echocardiography parameters. IVRT in FDM differed from that in FC, whereas no significant differences were observed in any of the parameters between FO and FC. The literature is somewhat equivocal regarding the predictive value of inflow Doppler and MPI in assessing myocardial function abnormalities in the fetal heart. Wong et al. found normal MPI in the first and second trimesters and lower MPI in the third trimester in fetuses of women with gestational DM 22 . Turan et al. observed an abnormal E : A ratio and MPI from the first trimester 23 . However, others have demonstrated no change in MPI or mitral E : A ratio in FDM [24] [25] [26] . We, and others, believe that MPI is less reliable as an indicator of myocardial function 27 . When first proposed by Tei et al., they demonstrated that MPI in adults correlated with simultaneous catheterization-derived LV + dP/dt 28 . However, Cheung et al. subsequently found MPI to be load sensitive, with no consistent relationship with cardiac function 27 . Previous literature and our results suggest the need for a reliable and reproducible technique in assessing fetal cardiac function. The present investigation supports the use of 2D-STE as a reproducible and valid alternative for fetal cardiac function evaluation.
Parameters of myocardial deformation were decreased in comparison with normal fetuses, suggesting altered systolic ventricular function in FDM and FO. Previous studies using tissue Doppler echocardiography have observed increased systolic myocardial velocities and myocardial lengthening in FDM 29, 30 . They suggested that these changes might reflect fetal cardiovascular adaptation to high biventricular output, secondary to increased total placental capillary volume and surface area in FDM 29, 31, 32 . Alternatively, considerable clinical and experimental evidence supports the theory that intrinsic myofibrillar derangement in FDM and FO results from fetal metabolic and epigenetic perturbations associated with maternal systemic disease. For example, using 2D-STE, Wang et al. found significantly decreased peak systolic strain in the apical segments of the IVS and left ventricular lateral wall in FDM 33 . Others have shown that left ventricular strain and strain rate using tissue Doppler are reduced in FO 34 . Myocardial changes persist postnatally in infants of diabetic mothers, with reduced longitudinal strain and impaired systolic function on 2D-STE 35 . In the Tomtec algorithm, the depth of tracking is a proportion of the length of the tracked segment, an important factor with respect to the thin fetal myocardium. We have therefore reported only global strain (and not regional strain) in this study. Reporting of global strain values in the fetus is supported by others 36 . Advances in techniques for strain analysis may allow for accurate quantification of regional strain in the fetus and may provide further insights into the myocardial abnormalities in these patients. Our results show decreased myocardial deformation in all three principal directions (longitudinal, circumferential and radial) in FDM, indicating a diffuse pattern of myocardial involvement, as has been reported for cardiomyopathies 37 . This supports a true myopathic, rather than adaptive, pathogenesis.
Preclinical studies indicate the possibility of multiple mechanisms that may alter myocardial function in FDM and FO, which probably share several pathogenic pathways. For example, a prenatal high-fat diet in pregnant mice causes cardiac hypertrophy and contractile defect in the offspring through complex cellular mechanisms 3 . Another preclinical study found increased collagen and connective tissue accumulation, and upregulation of the transforming growth factor β/p38 signaling pathway in the myocardium of FO 4 . A maternal high-fat diet causes major alterations in cardiac microRNA expression in baboon fetuses 38 .
In-vitro studies have demonstrated that survivin, a protein with antiapoptotic properties, is attenuated by hyperglycemia and hypoxia 39 . Survivin-deficient hearts display increased cell size to compensate for the decrease in cell number 40 . Others have demonstrated an increased risk of metabolic disease, including hyperinsulinemia and disrupted lipid metabolism, in the offspring from maternal insulin resistance 41 . The roles of the multiple mechanisms that may alter fetal myocardium in FDM and FO are yet to be defined completely. Our study extends these cellular observations into the clinical realm by demonstrating morphological manifestations in the fetal heart using advanced imaging.
We acknowledge that our study has some limitations. The cross-sectional nature of this study does not allow evaluation of the impact of maternal medical intervention on the fetal myocardium or the outcome of the fetuses. A significant proportion of mothers in the FDM group were obese, and we demonstrated with subgroup analysis of non-obese FDM that strain parameters remained abnormal in this group. There may have been a referral bias in FDM and FO mothers as they were enrolled into the study after being referred for standard clinical indications. Images for this study were obtained according to specific criteria, detailed above, but in actual clinical practice it may not always be possible to obtain the required high-frame-rate images. Given the width of the fetal myocardium, there is a limit to the spatial resolution achieved in fetal echocardiography. Although we have demonstrated acceptable interobserver and intraobserver concordance, it is advisable in clinical practice to use caution when interpreting strain parameters, especially radial strain 14, 36 . FDM and FC were recruited at two separate centers; however, results from interobserver agreement suggest good reproducibility of measurements at both institutions. This was facilitated by strict adherence to the protocol and use of similar equipment and software for image acquisition and postprocessing at both centers.
In conclusion, this investigation characterizes myocardial mechanics of the fetal heart in pregnancies with DM and obesity, the two largest epidemics of this century. Unfavorable changes in cardiac function occur in fetuses of diabetic and obese mothers. Whether the observed findings are transient, precede late-trimester left ventricular hypertrophy or might have long-term prognostic significance cannot be addressed by the current work, and further studies are needed.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article: Figure S1 Bland-Altman analysis of intraobserver agreement for global longitudinal strain (GLS), global circumferential strain (GCS), average radial strain (ARS), average longitudinal systolic strain rate (ALSR) and average circumferential systolic strain rate (ACSR). Plot represents mean difference (green line) and limits of agreement (brown lines).
Figure S2
Bland-Altman analysis of interobserver agreement for global longitudinal strain (GLS), global circumferential strain (GCS), average radial strain (ARS), average longitudinal systolic strain rate (ALSR) and average circumferential systolic strain rate (ACSR). Plot represents mean difference (green line) and limits of agreement (brown lines).
Videoclip S1
Postprocessing technique for obtaining strain curves (see optimal image settings in Subjects and Methods) using Tomtec automated algorithm on images of fetal echocardiography. Single cardiac cycle may be selected, starting with image frame immediately prior to complete mitral valve closure or using M-mode (as demonstrated here).
